FDA Inspection 1275203 — Eduard F.W. Krantz
The FDA completed an inspection of Eduard F.W. Krantz on Jun 6, 2025 in Bloemfontein. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bloemfontein (South Africa)
Additional Details
Clinical BA/BE